Faces of Digital Health
F039 Patient behavior: what to consider when designing solutions? (Claire Kamoun)
Patients are getting increasingly engaged in their treatments, becoming the decisionmakers not just recipients of care. But to design a successful solution for patient support with high user retention is, to put it mildly, an art. Every patient lives in a different home environment, has different personal goal and challenges, therefore a good disease management solution for patients needs to be highly personalized. The discussion you will hear today is focused on exactly that: what aspects to take into account when we’re addressing patient behavior and patient empowerment, to which extent can technology decrease the need for real-life human coaches, since last years have shown that apps work best in combination with coaches. I spoke to Claire Kamoun – executive director of patient innovation at the French company MedClinik. Claire also shared her thoughts on technology adoption in France.
Coming soon: Digital health in Asia series
Asia is the 2nd largest digital health ecosystem in the world. Investments in the sector totaled 6.3 billion in 2018. 5 Faces of digital health episodes are going to be published in July, offering an overview of the region, and some insights provided by speakers from China, Singapore, South Korea and India.
F038 What do you know about the African healthcare market? (Moka Lantum)
Developing countries are often seen as ideal test hubs for innovation: there’s no existing infrastructure to disrupt, the regulation permits a faster speed of adoption. However, like any market, African countries have their own specifics. How can you scale in Africa? Can you reduce the price of your consumer solution to the affordability of African consumers? Moka Lantum, based in Kenya, is an expert on the African healthcare market. He obtained his Doctor of Medicine training at Faculty of Medicine and Biomedical Sciences, University of Yaoundé, Cameroon; a Diploma in Nutrition and International Child Health, from Uppsala University, Uppsala, Sweden; a Doctorate in Pharmacology, from the University of Rochester, Rochester, New York. He is a graduate of the Masters in Health Care Management at the Harvard School of Public Health. He has rich entrepreneurship history of developing solutions for the African market.
F037 G4A and the evolution of the digital health ecosystem (Eugene Barukhovich, G4A)
G4A, formerly known as Grants4Apps is probably the most famous digital health accelerator inside a Pharma conglomerate. For a few years, the program was designed to support a handful of startups by offering them office space, various entrepreneurship skills training and network expansion. As the digital health market evolved, so has the program, with Eugene Barukhovich taking over the global head of G4A digital health development at Bayer in 2016. At the moment, G4A is present in some form or another in 35 countries. 8 accelerators/incubators run around the globe. This discussion explains how a global pharmaceutical corporation with almost 120.000 employees launched a digital health accelerator, what are the specifics of this year’s application process, how are business scandals of digital health and biotech startups from the Silicon Valley affecting the ecosystem, Eugene briefly comments the Dutch and German digital health system.
To learn more about this year’s G4A program and application, see this link: http://bit.ly/2JL1gWo You have until May 31st to apply!
F036 How is AI decoding aging? (Alex Zhavoronkov, Insilico Medicine)
Longevity, eternal youth or even immortality have been an aspiration in religion and culture throughout history. Today, people adopt all sorts of approaches to increase their wellbeing, delay aging and avoid diseases. Efforts are increasingly quantified with sensors, wearables, or even biohacking - interventions to influence body biology. The new hope for advancements in longevity is seen in artificial intelligence, which is becoming increasingly powerful. Alex Zhavoronkov has been researching the use of AI in aging for years. He is the CEO of Insilico Medicine, a Baltimore-based leader in the next-generation artificial intelligence technologies for drug discovery and aging biomarkers discovery. He truly is a well of knowledge - since 2012 he published over 130 peer-reviewed research papers and 2 books including “The Ageless Generation: How Biomedical Advances Will Transform the Global Economy” (Palgrave Macmillan, 2013).
In this episode, he talks about the complexity of aging as a biological process, types of artificial intelligence and the role of AI in research advancements.
Some of his latest research articles include:
Blood Biochemistry Analysis to Detect Smoking Status and Quantify Accelerated Aging in Smokers – https://www.nature.com/articles/s41598-018-35704-w#author-information
Artificial intelligence for aging and longevity research: Recent advances and perspectives – https://www.sciencedirect.com/science/article/pii/S156816371830240X?via%3Dihub
Artificial Intelligence for Drug Discovery, Biomarker Development, and Generation of Novel Chemistry – https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.8b00930
Listen also:
F013 What to expect from artificial intelligence in healthcare in the next 10 years? (Sally Daub, Enlitic)
https://medium.com/faces-of-digital-health/f013-what-to-expect-from-artificial-intelligence-in-healthcare-in-the-next-10-years-fdaf2edf32f8
F035 Estonia: To which extent does the digital infrastructure support healthcare? (Hannalore Taal)
Estonia has only 1,3 million people but is famous worldwide for its digital governance. If you want, you can even become an Estonian electronic resident and run your business from Estonia, regardless of your country of residence. Healthcare wise, 95% of healthcare data is in digital form, some of it supported with blockchain technology. What does all this mean – is data structured or is information stored in pdf? How supportive is the system for digital health startups? And how did the country, where only 6.5% of the GDP is spent on healthcare, achieve the level of digitization many countries are only dreaming of? Hannalore Taal – digital health specialist and the Chief e-Health Specialist at the Estonian Ministry of Social Affairs explains.
Responses